rat different group show significant difference initial latency il acquisition phase fig 1a contrary retention trial sco rat e rat demonstrate markedly le step latency stl control fig 1b 2 week low high 5 10 mgkgday 2 week respectively iva treatment well standard ad medication donepezil 0.5 mgkgday 2 week treatment rat display significant increase stl compare e rat fig 1b rat memorize presence darkroom associate aversive stimulus foot shock moreover prolong escape latency position formerly submerge platform significantly reduce manner comparable effect donepezil rat different experimental group show gradual decrease mean escape latency hide platform throughout 6 successive day acquisition trial reflect acquisition learn table 1. probe trial e rat show le time spend target quadrant search miss platform notably longer latency find position escape platform vs. control rat fig 1c likewise administration high iva donepezil e group significantly attenuate decrease time spend target quadrant 7th day indicate memory retrieval fig 1c exception lower dose iva whose effect escape latency significant time spend target quadrant nonsignificant fig 1c show fig 1e significant difference exploration time object object b size form among experimental group sco e group unable distinguish familiar object novel object fig 1f significant increase novel object recognition time restore treatment donepezil do iva fig 1f compare normal control e group demonstrate significantly higher hippocampal level inflammatory cytokine tnfα il2 il6 fig 2ac high cytokine level couple significant increase lipid peroxidase mda level e group compare control group fig 2d additionally significant decrease superoxide dismutase sod total antioxidant capacity tac level e group compare control group fig 2e f analysis hippocampal homogenate use elisa technique validate behavioural result significant decrease elevate level tnfα il2 il6 low high iva donepezil compare e group fig 2ac moreover significant decrease level mda low high iva group donepezil compare e group fig 2d additionally significant increase level sod tac low high iva donepezil compare e group fig 2e f brain hippocampal size group ii administrate sco 6 mgkgday 21 day group iii e group 4 mgkgday 28 day decrease weight brain group ii group iii mark decrease group iii compare control table 2. moreover significant decrease crosssectional area csa sagittalparasagittal section brain exclude cerebellum bec group ii group iii slight decrease group ii significant decrease group iii perimeter sagittal section bec group ii compare control table 2. significant decrease csa perimeter sagittal section hippocampus group ii group iii compare control table 2. present study investigate histopathological change record change situ record parameter cellular density organization thickness number cellular row pyramidal layer ca granular cell dg could display level neurodegeneration also investigate histopathological characteristic neuronal cell type hippocampus control group cell arrange closely consistent size show welldefined cytoplasm cytoplasmic nuclear membrane clearly visible nucleolus table 3 fig 3ac group ii thickness pyramidal layer distance 2 imaginary line pass pyramidal cell decrease significantly ca1 insignificantly ca2 ca3 compare control table 3 fig 3df exposure sco result sign mild neurodegeneration balloon cell bc notice phenomenon group ii appearance nucleus condense densely eosinophilic core meanwhile cytoplasm present appear foamy group iii thickness pyramidal layer decrease significantly ca2 ca3 compare control table 3 fig 3gi moreover ca3 hilum show elongate cell along large distance cell main cause increase thickness layer fig 3i elongate cell pyramidal layer subfields cornu ammonis ca1 ca2 ca3 fig 3gi exaggerate sign neurotoxicity one rat e fig 3jl ca1 pyramidal cell dramatically reduce arrange onetwo row become intensively stain fig 3j moreover ca2 pyramidal cell deform dysmorphic shape triangular elongate star shape balloon cell cytoplasmic achromasia fig 3k large space many nucleus glia cell see ca2 cell fig 3k ca3 cell disappear vacuole see instead fig 3l control group granular cell dg appear round large round nucleus contain prominent nucleolus surround thin cytoplasm notice small dark eosinophilic cell variable shape towards interior dg normal density glial cell nucleus table 3 fig 4a b group ii group iii significant decrease thickness granular layer dg compare control table 3 fig 4cf group ii majority cell granular layer hilum bc notice also moderate density glial cell nucleus indicate mild gliosis group iii sg dg along cell hilum involve densely stain elongate cell lot bc moderate density glial cell nucleus indicate mild gliosis one rat e group iii show highly deform hippocampus dg hilum granular cell drastically reduce leave remain cell remain cell become condense dysmorphic separate large space fig 4g take together behavioural test elisa analysis histopathological result show extend scopolamine administration group show greatest sign behavioural impairment learn memory deficit demented brain degenerate hippocampus therefore rat expose e use analysis ivabradine effect use three group e rat sco 4 mgkgday 28 day analysis cessation sco administration group iv receive low dose iva 5 mgkgday 14 day group v receive high dose iva 10 mgkgday 14 day group vi receive donepezil one already validate medication alzheimer disease 0.5 mgkgday 14 day three group brain weight restore group iv v vi healthier average compare group iii table 2. confirm significant increase csa perimeter sagittal section bec compare group iii furthermore significant increase csa perimeter sagittal section hippocampus compare group iii table 2. pyramidal layer ca1 ca2 ca3 hilum three group ivvi show normal healthy cell le deform cell group iii fig 5al group iv thickness number pyramidal layer ca1 ca2 ca3 increase however insignificantly compare group iii table 3 fig 5df mo notably pyramidal layer ca2 show dense cell separate large distance fig 5e group v thickness pyramidal layer restore significantly ca3 along insignificant increase ca1 ca2 compare group iii table 3 fig 5gi mo notably pyramidal cell ca2 ca3 separate large distance fig 5h group vi thickness number pyramidal layer ca1 ca3 increase significantly insignificantly ca2 compare group iii table 3 fig 5jl mo pyramidal layer ca2 ca3 show densely stain cell fig 5k l additionally pyramidal cell ca3 separate large distance result increase thickness fig 5l moreover severely affect rat exhibit dg hilum granular cell drastically reduce become condense irregular surround large space ca3 disappear vacuole see instead ca2 pyramidal cell deform irregular shape moreover large space many nucleus glia cell see ca2 cell ca1 pyramidal cell dramatically decrease arrange one row become intensively stain three group significant increase thickness granular layer dg table 3 fig 6a c e g mean number cell hilum increase compare group iii 8 cell table 3 fig 6b f h inner layer granular layer dg dense small three group small distance remain cell outer layer group iv fig 6c recover e group donepezil group show outer normal cell granular layer dg high density glial cell nucleus indicate active gliosis three group cell hilum triangular densely stain donepezil administration fig 6h cut hemisphere stain congo red dye detect deposition beta amyloid plaque administration sco group ii merely one plaque diameter 30 08m observe compare control group plaque whereas e group iii result multifocal deposition amyloid beta plaque 8 plaque variable size 20 × 3 30 50 60 70 100 08m observe fig 7. result confirm e highest adverse effect brain cessation sco administration low dose iva giv deposition amyloid beta plaque disappear completely however decrease number 5 plaque reduce size 20 40 08m compare giii interestingly case administration higher dose iva group v period deposition amyloid beta plaque disappear stain slide donepezil administrate group show comparable result higher dose iva deposition amyloid beta plaque disappear hippocampal section process simultaneously image capture use fix microscope parameter briefly least 10 different hcn1immunoreactive cell different subfields hippocampus 3 different section three replicate measure mean maximum grey intensity measure use image j software optical density hcn1 immunoreactivity calculate accord follow equation od log max gray intensitymean gray intensity find od hcn1 immunoreactivity group ii 3 week sco injection comparable control group different subfields hc table 4 fig 8af 9ad however decrease significantly e group iii different subfields hippocampus compare control group ii table 4 fig 8gi 9e application iva observe optical density hcn1 immunoreactivity increase dramatically low high iva group iv v donepezil group vi hippocampal subfields compare e group iii table 4 fig 10ao 11ai use scopolamine induce dementia model 4 mgkg 28 day investigate effect ivabradine consecutive 15 day cognitive function ensure amelioration due either iva donepezil group administrate scopolamine 4 mgkg 28 day leave 15 day without administrate medication behavioural test perform sacrifice biochemical conventional histopathological examination assess find group recover level control group publish \<SEP>1